Regulus Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Aug '25 Aug 8, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Market Capitalization	69	79	91	-
Market Cap Growth	6.35%	-12.71%	-	-
Enterprise Value	54	66	79	-
Last Close Price	1.29	10.81	10.17	-
PE Ratio	46.98	9.61	23.97	-
PS Ratio	1.65	0.55	0.54	-
PB Ratio	2.21	2.33	3.55	-
P/TBV Ratio	2.61	2.76	4.52	-
P/FCF Ratio	322.47	26.01	41.77	-
P/OCF Ratio	300.54	25.15	41.48	-
EV/Sales Ratio	0.45	0.45	0.47	-
EV/EBITDA Ratio	10.28	7.14	19.16	-
EV/EBIT Ratio	12.56	7.90	25.14	-
EV/FCF Ratio	250.74	21.64	36.43	-
Debt / Equity Ratio	0.01	0.02	0.02	0.04
Debt / EBITDA Ratio	0.06	0.07	0.09	0.19
Debt / FCF Ratio	1.66	0.23	0.18	-
Asset Turnover	-	2.72	3.26	-
Quick Ratio	1.64	1.88	1.14	1.40
Current Ratio	2.32	2.46	1.56	1.73
Return on Equity (ROE)	15.90%	28.82%	16.72%	-
Return on Assets (ROA)	-	9.75%	3.82%	-
Return on Capital (ROIC)	8.64%	17.19%	7.84%	-
Return on Capital Employed (ROCE)	13.70%	24.30%	12.30%	13.20%
Earnings Yield	7.15%	10.40%	4.17%	-
FCF Yield	0.31%	3.84%	2.39%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.